维普中文期刊产品整合服务
11篇 您的检索式:作者名="Damy F"
    题名 作者 年代 出处 被引量
1Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects显示文摘Damy T Pousset F Caplain H 2004Fundam Clin Pharmacol2004,18,1:1
2Pharmacokinet- ic and phar - macodynamic interactions between metop rolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects 显示文摘Damy T Pousset F Caplain H 2004Fun - dam Clin Pharmacol2004,18,1:1
3The effects of forest fragmentation on species richness on the Obudu Plateau,south-eastern Nigeria显示文摘Dami F D Mwansat G S Manu S A 0,,01:1
4Why bystanders decline telephone cardiac resuscitation advice显示文摘Dami F Carron PN Prsz L 2010Acad Emerg Med2010,17,9:1
5Pharmacokinetic and pharmacodynamic interactions between metoprolol and drone- darone in extensive and poor CYP2D6 metabolizers healthy sub- jects 显示文摘DAMY T POUSSET F CAPLAIN H 2004Fundam Clin Pharmacol2004,18,1:1
6Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines显示文摘Vermeulen F Verscheure V Damis E 2010Clin Vaccine Immunol2010,17,2:1
7Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii 显示文摘Damy F Deslee D Santoro F 1988Parasite Immuno11988,10,5:1
8Cellular immuneresponses of preterm infants after vaccination with whole-cellor acellular pertussis vaccines显示文摘Vermeulen F Verscheure V Damis E 2010Clin Vaccine Immunol2010,17,2:1
9Pharmackkinetics and safety of singh oral doses of amlodipine in patients whch and without hepatic: an open study显示文摘Damis F Poupon R 1993Int J Clin Pharmacol Res1993,13,1:1
10Nanotubular erosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymaI stem cells 显示文摘Figeac F Lesault P F Coz O L Damy T Souktani R Trebeau C 2014Stem Cells2014,32,:1
11Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak:Results from a nationwide survey显示文摘BACKGROUND Coronavirus disease 2019(COVID-19)pandemic is still evolving globally,and Brazil is currently one of the most affected countries.It is still debated whether patients with inflammatory bowel disease(IBD)are at a higher risk for developing COVID-19 or its complications.AIM To assess geographical distribution of IBD patients at the highest risk and correlate these data with COVID-19 mortality rates in Brazil.METHODS The Brazilian IBD Study Group(Grupo de Estudos da Doença Inflamatória Intestinal do Brasil)developed a web-based survey adapted from the British Society of Gastroenterology guidelines.The included categories were demographic data and inquiries related to risk factors for complications from COVID-19.Patients were categorized as highest,moderate or lowest individual risk.The Spearman correlation test was used to identify any association between highest risk and mortality rates for each state of the country.RESULTS A total of 3568 patients(65.3%females)were included.Most participants were from the southeastern and southern regions of Brazil,and 84.1%were using immunomodulators and/or biologics.Most patients(55.1%)were at moderate risk,23.4%were at highest risk and 21.5%were at lowest risk of COVID-19 complications.No association between the proportion of IBD patients at highest risk for COVID-19 complications and higher mortality rates was identified in different Brazilian states(r=0.146,P=0.467).CONCLUSION This study indicates a distinct geographical distribution of IBD patients at highest risk for COVID-19 complications in different states of the country,which may reflect contrasting socioeconomic,educational and healthcare aspects.No association between high risk of IBD and COVID-related mortality rates was identified.Natália Sousa Freitas Queiroz Fábio Vieira Teixeira Marina Pamponet Motta Liliana Andrade Chebli Adriano Akira Ferreira Hino Camilla de Almeida Martins Abel Botelho Quaresma Alexandre Augusto de Paula da Silva Adérson Omar Mourão Cintra Damião Rogerio Saad-Hossne Paulo Gustavo Kotze 2021World Journal of Gastroenterology2021,27,12:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费